Meta-analysis of the Hachinski ischemic score in pathologically verified dementias

Neurology

Volumn 49, Issue 4, 1997, Pages 1096-1105

  Moroney, J T ^a   Bagiella, E ^a   Desmond, D W ^a,e   Hachinski, V C ^f   Molsa P K ^f   Gustafson, L ^c   Brun, A ^c   Fischer, P ^d   Erkinjuntti, T ^f   Rosen, W ^b   Paik, M C ^a   Tatemichi, T K ^a  

^a Columbia University ^*  (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e NEUROLOGICAL INSTITUTE   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC VALUE; HUMAN; META ANALYSIS; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0343812095     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.4.1096     Document Type: Article

References (60)

1. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
2. Mayer-Gross W, Slater E, Roth M. Clinical psychiatry, 3rd ed. Baltimore: Williams and Wilkins, 1969.
3. Rothschild D. Neuropathologic changes with arteriosclerotic psychosis and their psychiatric significance. Arch Neurol Psychiatry 1942;48:417-436.
4. Corsellis JAW. Mental illness and the ageing brain. London: Oxford University Press, 1962.
5. Tatemichi TK. How acute brain failure becomes chronic: a view of the mechanisms of dementia related to stroke. Neurology 1990;40:1652-1659.
6. Erkinjuntti T, Hachinski VC. Rethinking vascular dementia. Cerebrovasc Dis 1993;3:3-23.
7. Drachman DA. New criteria for the diagnosis of vascular dementia: do we know enough yet? Neurology 1993;43:243-245.
8. Desmond DW. Vascular dementia: a construct in evolution. Cerebrovasc Brain Metab Rev 1996;8:296-325.
9. Liston EH, La Rue A. Clinical differentiation of primary degenerative and multi-infarct dementia: a critical review of the evidence. Part 1: Clinical studies. Biol Psychol 1983;18:1451-1465.
10. Liston EH, La Rue A. Clinical differentiation of primary de generative and multi-infarct dementia: a critical review of the evidence. Part 2: Pathological studies. Biol Psychol 1983;18: 1467-1484.
11. Dening TR, Berrios GE. The Hachinski Ischemic Score: a reevaluation. Int J Ger Psychol 1992;7:585-589.
12. McKhann G, Drachman DA, Folstein F, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
13. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part 1. Clinical and neurological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
15. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42: 473-480.
16. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43: 250-260.
17. World Health Organization. The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research. Geneva, Switzerland: World Health Organization, 1993:36-40.
18. Lopez OL, Swihart AA, Becker JT, et al. Reliability of NINCDS-ADRDA clinical criteria for the diagnosis of Alzheimer's disease. Neurology 1990;40:1517-1522.
19. Lopez OL, Larumbe MR, Becker JT, et al. Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology 1994;44:1240-1245.
20. Wetterling T, Kanitz RD, Borgis KJ. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996;27:30-36.
21. Meyer JS, Judd BW, Talat T, Rogers RL, Mortel KF. Improved cognition after control of risk factors for multi-infarct dementia. JAMA 1986;256:2203-2209.
22. Meyer JS, Muramatsu K, Mortel KF, Obara K, Shirai T. Prospective CT confirms differences between vascular and Alzheimer's dementia. Stroke 1995;26:735-742.
23. Wade JPH, Mirsen TR, Hachinski VC, Fisman M, Lau C, Merskey H for the University of Western Ontario Dementia Study Group. The clinical diagnosis of Alzheimer's disease. Arch Neurol 1987;44:24-29.
24. Mölsä PK, Paljärvi L, Rinne Jo, Rinne UK, Säkö E. Validity of clinical diagnosis in dementia: a prospective clinicopathological study. J Neurol Neurosurg Psychiatry 1985;48:1085-1090.
25. Brun A, Gustafson L. The Lund longitudinal dementia study: a 25 year perspective on neuropathology, differential diagnosis, and treatment. In: Corain B., et al., eds. Alzheimer's disease: advances in basic and clinical research. Chicester; New York: J. Wiley, 1993:3-18.
26. Fischer P, Jellinger K, Gatterer G, Danielczyk W. Prospective neuropathological validation of the Hachinski Ischemic Score in dementias. J Neurol Neurosurg Psychiatry 1991;54:580-583.
27. Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 1988;51:1037-1044.
28. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-488.
29. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Press, 1980.
30. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Press, 1987. Rev.
31. Fuld PA. Psychological testing in the differential diagnosis of the dementias. In: Katzman R, Terry D, Bick KL, eds. Alzheimer's disease: senile dementia and related disorders. New York: Raven Press, 1978:185-193.
32. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285-1293.
33. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988;38:359-364.
34. Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Hyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 1995;45:461-466.
35. Portera-Sanchez A, del Ser T, Bermajo F, Arredondo JM. Clinical diagnosis of senile dementia of Alzheimer's type and vascular dementia. In: Terry RD, Bolis CL, Tofano G, eds. Neural ageing and its implications on human neurological pathology. New York: Raven Press, 1982:169-188.
36. Loeb C. Clinical diagnosis of multi-infarct dementia. In: Amaducci L, Davison AN, Antuono P, eds. Aging of the brain and dementia. New York: Raven Press, 1980:251-260.
37. Wagner O, Oesterreich K, Hoyer S. Validity of the ischemic score in degenerative and vascular dementia and depression in old age. Arch Gerontol Geriatr 1985;4:333-345.
38. Harrison MJG, Thomas DJ, Du Boulay GH, Marshall J. Multi-infarct dementia. J Neurol Sci 1979;40:97-103.
39. Wikkelso C, Blomstrand C, Nordquist P. Cerebrospinal fluid investigations in multi-infarct dementia and senile dementia. Acta Neurol Scand 1981;64:1-11.
40. Amar KA, Wilcock GK. Vascular dementia [letter]. Neurology 1995;45:1423-1424.
41. Katzman R, Aronson M, Fuld P, et al. Development of dementing illness in an 80-year-old volunteer cohort. Ann Neurol 1989;25:317-324.
42. Kenny RA, Stevens S, Hodkinson HM. Hachinski Ischemic Score in demented elderly patients. Clin Exp Gerontol 1984;6: 63-74.
43. Larson DB, Lyons JS, Bareta JC, Burns BJ, Blazer DG, Goldstrom ID. The construct validity of the ischemic score of Hachinski for the detection of dementias. J Neuropyschol 1989;1:181-187.
44. Homer A, Honavar M, Lantos PL, Hastie IR, Kellett JM, Millard PH. Diagnosing dementia: do we get it right? BMJ 1988;297:894-896.
45. Bowen BC, Barker WW, Loewenstein PA, Sheldon J, Duara R. MR signal abnormalities in memory disorder and dementia. AJNR Am J Neuroradiol 1990;154:1285-1292.
46. Loeb C, Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia. Stroke 1983;14:399-401.
47. Brun A, Englund E. A white matter disorder in dementia of Alzheimer type: a pathoanatomical study. Ann Neurol 1986; 19:253-262.
48. Englund E, Brun A, Gustafson L. A white matter disease in dementia of Alzheimer's type: clinical and neuropathological correlates. Int J Ger Psychol 1989;4:87-102.
49. Passant U, Warkentin S, Karlson S, Nilsson K, Edvinsson L, Gustafson L. Orthostatic hypotension in organic dementia: relationship between blood pressure, cortical blood flow, and symptoms. Clin Auton Res 1996;6:29-36.
50. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
51. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer's disease: the Nun Study. JAMA 1997;277: 813-817.
52. Tatemichi TK, Desmond DW, Prohovnik I. Strategic infarcts in vascular dementia: a clinical and brain imaging experience. Arzneimittelforschung 1995;45:371-385.
53. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995;45:1161-1168.
54. Skoog I, Lemfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
55. Olichney JM, Hansen LA, Hofsetta CR, Grundman M, Katzman R, Thai LJ. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995;52:702-708.
56. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996;380:168-171.
57. Stewart LA, Clarke MJ. The practical methodology of metaanalyses (overview) using updated individual patient data. Cochrane Working Group. Stat Med 1995;14:2057-2079.
58. O'Brien PC. Meta-analysis: its role in medical research and in assessment of the association between low levels of cholesterol and excess mortality. Mayo Clin Proc 1993;68:91-93.
59. Saunders AM, Hulette C, Welsh-Bohmer KA, et al. Specificity, sensitivity, and predictive value of apolipoprotein E genotyping for sporadic Alzheimer's disease. Lancet 1996;348:90-95.
60. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-710.